Contributions of StubSorterBot

Contributions by StubSorterBot, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 28,844 edits includes activity predating the current log.

1. 07:27, 7 May 2025 (diff | hist) Counterfeit peptide 4,235 +233 m b bot: update parent category chain
2. 02:13, 6 May 2025 (diff | hist) Shanghai Wibson Biotechnology 7,557 +1,145 m b bot: add supplier category
3. 10:27, 3 May 2025 (diff | hist) Amino acid analysis 4,038 ±0 m b bot: sort category members
4. 18:49, 28 Apr 2025 (diff | hist) Sigma-Aldrich (Shanghai) Trading 2,963 +38 m b bot: update parent category chain
5. 14:58, 17 Apr 2025 (diff | hist) Baseline laboratory panel 3,526 +487 m b bot: update parent category chain
6. 06:24, 13 Apr 2025 (diff | hist) Dulaglutide 4,161 ±0 m b bot: expand DOI to full citation
7. 23:04, 20 Mar 2025 (diff | hist) CagriSema 3,887 ±0 m b bot: repair redlinked category
8. 09:29, 20 Mar 2025 (diff | hist) Proglucagon 5,725 ±0 m b bot: normalise citation format
9. 11:10, 11 Mar 2025 (diff | hist) Drug master file 3,180 +104 m b bot: update parent category chain
10. 19:56, 23 Feb 2025 (diff | hist) Counterfeit peptide 2,733 ±0 m b bot: normalise citation format
11. 02:42, 23 Feb 2025 (diff | hist) Trifluoroacetate counterion 3,489 +25 m b bot: sort category members
12. 22:29, 21 Feb 2025 (diff | hist) GL Biochem (Shanghai) 10,795 +483 m b bot: update parent category chain
13. 10:38, 10 Feb 2025 (diff | hist) Tianjin Finder Chemical 6,168 +351 m b bot: mark outbound storefront link nofollow
14. 14:19, 24 Jan 2025 (diff | hist) LEADER trial 3,277 +99 m b bot: sort category members
15. 01:47, 12 Jan 2025 (diff | hist) Arcuate nucleus 3,773 +36 m b bot: sort category members
16. 23:52, 3 Jan 2025 (diff | hist) Deamidation 3,497 +602 m b bot: sort category members
17. 17:03, 2 Jan 2025 (diff | hist) GLP-1 receptor 5,522 ±0 m b bot: normalise citation format
18. 17:02, 29 Dec 2024 (diff | hist) Amylin receptor agonist 3,505 +600 m b bot: expand DOI to full citation
19. 15:20, 26 Dec 2024 (diff | hist) Test report forgery 2,909 ±0 m b bot: update parent category chain
20. 17:50, 25 Dec 2024 (diff | hist) Tirzepatide 5,389 +44 m b bot: add drug-class category
21. 15:25, 24 Dec 2024 (diff | hist) Melanotan II 2,511 +541 m b bot: add stub category
22. 06:28, 23 Dec 2024 (diff | hist) Sangon Biotech 2,454 +283 m b bot: normalise citation format
23. 18:21, 21 Dec 2024 (diff | hist) Third-party testing 5,061 ±0 m b bot: flag bare reference
24. 19:07, 6 Dec 2024 (diff | hist) Chain of custody 2,966 ±0 m b bot: normalise citation format
25. 06:40, 5 Dec 2024 (diff | hist) Fasting insulin 2,254 ±0 m b bot: normalise unit spacing
26. 21:29, 29 Nov 2024 (diff | hist) Retention time 2,901 ±0 m b bot: flag bare reference
27. 21:13, 29 Nov 2024 (diff | hist) Glucagon-like peptide-1 8,227 ±0 m b bot: sort category members
28. 15:20, 22 Nov 2024 (diff | hist) Subcutaneous injection 3,690 +704 m b bot: repair redlinked category
29. 15:07, 20 Nov 2024 (diff | hist) Purity claim inflation 2,670 +432 m b bot: normalise citation format
30. 10:14, 16 Nov 2024 (diff | hist) Lyophilisation 10,259 +907 m b bot: flag bare reference
31. 21:16, 13 Nov 2024 (diff | hist) Adverse effects of GLP-1 receptor agonists 3,171 +34 m b bot: flag bare reference
32. 17:37, 13 Nov 2024 (diff | hist) Chinese Peptide Company 5,897 ±0 m b bot: add supplier category
33. 22:47, 6 Nov 2024 (diff | hist) Vial filling and stoppering 2,015 ±0 m b bot: normalise temperature formatting
34. 23:20, 1 Nov 2024 (diff | hist) International nonproprietary name 1,833 ±0 m b bot: normalise citation format
35. 20:37, 1 Nov 2024 (diff | hist) Enteroendocrine L cell 3,351 ±0 m b bot: expand PMID to full citation
36. 06:47, 30 Oct 2024 (diff | hist) Chain of custody 2,966 +33 m b bot: add maintenance category
37. 12:41, 21 Oct 2024 (diff | hist) PeptideMeter 2,760 ±0 m b bot: sort category members
38. 12:44, 14 Oct 2024 (diff | hist) Vial 11,177 +1,970 m b bot: update parent category chain
39. 11:01, 12 Oct 2024 (diff | hist) Reverse-phase HPLC 3,045 ±0 m b bot: flag bare reference
40. 18:47, 3 Oct 2024 (diff | hist) Preparative HPLC purification 2,696 +388 m b bot: normalise unit spacing
41. 08:38, 1 Oct 2024 (diff | hist) Peptide content 2,529 +574 m b bot: flag bare reference
42. 06:44, 28 Sep 2024 (diff | hist) VendorInvestigate 2,593 +403 m b bot: normalise citation format
43. 22:16, 21 Sep 2024 (diff | hist) Reconstitution calculator 1,663 +298 m b bot: repair redlinked category
44. 05:57, 8 Sep 2024 (diff | hist) SURMOUNT trial programme 2,536 +479 m b bot: expand DOI to full citation
45. 21:01, 31 Aug 2024 (diff | hist) Dual incretin agonist 3,191 +635 m b bot: add drug-class category
46. 11:14, 25 Aug 2024 (diff | hist) Chinese Peptide Company 2,675 ±0 m b bot: normalise citation format
47. 13:36, 31 Jul 2024 (diff | hist) GLP-1 receptor agonist 4,181 +1,393 m b bot: sort category members
48. 01:19, 30 Jul 2024 (diff | hist) Reconstitution of lyophilised peptides 2,816 +745 m b bot: sort category members
49. 06:50, 28 Jul 2024 (diff | hist) Bacteriostatic water 2,332 +482 m b bot: repair redlinked category
50. 01:00, 27 Jul 2024 (diff | hist) Glucose-dependent insulinotropic polypeptide 3,368 +817 m b bot: flag bare reference
51. 23:16, 25 Jul 2024 (diff | hist) Adverse effects of GLP-1 receptor agonists 2,045 ±0 m b bot: expand PMID to full citation
52. 04:19, 23 Jul 2024 (diff | hist) Semaglutide 3,178 ±0 m b bot: add drug-class category
53. 07:57, 11 Jul 2024 (diff | hist) GLP-1 receptor 3,125 +294 m b bot: sort category members
54. 13:15, 24 Jun 2024 (diff | hist) Semaglutide 2,577 ±0 m b bot: sort category members